Abstract:This study aimed to use spatiotemporal PET imaging to investigate the dynamic metabolic changes after a combined therapeutic approach of induced pluripotent stem cells (iPSCs), neuronal stem cells (NSCs), and Chinese patent medicine in a rat model of cerebral ischemia-reperfusion injury. Methods: Cerebral ischemia was established by the middle cerebral artery occlusion approach. Thirty-six male rats were randomly assigned to 1 of the 6 groups: control phosphate-buffered saline (PBS), Chinese patent medicine (Qing-kai-ling [QKL]), induced pluripotent stem cells (iPSCs), combination of iPSCs and QKL, neuronal stem cells (NSCs), and combination of NSCs and QKL. Serial F-18-FDG small-animal PET imaging and neurofunctional tests were performed weekly. Autoradiographic imaging and immunohistochemical and immunofluorescent analyses were performed at 4 wk after stem cell transplantation. Results: Compared with the PBS control group, significantly higher F-18-FDG accumulations in the ipsilateral cerebral infarction were observed in 5 treatment groups from weeks 1-4. Interestingly, the most intensive F-18-FDG accumulation was found in the NSCs + QKL group at week 1 but in the iPSCs + QKL group at week 4. The neurofunctional scores in the 5 treatment groups were significantly higher than that of the PBS group from week 3 to 4. In addition, there was a significant correlation between the PET imaging findings and neurofunctional recovery (P < 0.05) or glucose transporter-1 expression (P < 0.01). Immunohistochemical and immunofluorescence studies found that transplanted iPSCs survived and migrated to the ischemic region and expressed protein markers for cells of interest. Conclusion: Spatiotemporal PET imaging with F-18-FDG demonstrated dynamic metabolic and functional recovery after iPSCs or NSCs combined with QKL in a rat model of cerebral ischemia-reperfusion injury. iPSCs or NSCs combined with Chinese medicine QKL seemed to be a better therapeutic approach than these stem cells used individually.

Upregulating HIF‐1α to boost the survival of neural stem cells via functional peptides‐complexed MRI‐visible nanomedicine for stroke therapy

Upregulating Microrna‐210 to Inhibit Apoptosis of Neural Stem Cells with an MRI–Visible Nanomedicine for Stroke Therapy

Highly Effective Stroke Therapy Enabled by Genetically Engineered Viral Nanofibers

MRI-Visible siRNA Nanomedicine Directing Neuronal Differentiation of Neural Stem Cells in Stroke

Nanomedicine Directs Neuronal Differentiation of Neural Stem Cells Via Silencing Long Noncoding RNA for Stroke Therapy.

Multimodality Molecular Imaging of Stem Cells Therapy for Stroke.

Superparamagnetic Iron Oxide Nanoparticles-Complexed Cationic Amylose for In Vivo Magnetic Resonance Imaging Tracking of Transplanted Stem Cells in Stroke

Spatiotemporal Pet Imaging Of Dynamic Metabolic Changes After Therapeutic Approaches Of Induced Pluripotent Stem Cells, Neuronal Stem Cells, And A Chinese Patent Medicine In Stroke

A Novel Polymeric Micelle Used for in Vivo MR Imaging Tracking of Neural Stem Cells in Acute Ischemic Stroke

Ferrimagnetic Nanochains‐Based Mesenchymal Stem Cell Engineering for Highly Efficient Post‐Stroke Recovery

Stem Cell Labeling With Superparamagnetic Iron Oxide Nanoparticles Using Focused Ultrasound And Magnetic Resonance Imaging Tracking

Therapeutic effect on experimental acute cerebral infarction is enhanced after nanoceria labeling of human umbilical cord mesenchymal stem cells.

In Vivo Monitoring of Neural Stem Cells after Transplantation in Acute Cerebral Infarction with Dual-Modal MR Imaging and Optical Imaging

In Vivo Long-Term Tracking of Neural Stem Cells Transplanted into an Acute Ischemic Stroke Model with Reporter Gene-Based Bimodal MR and Optical Imaging

In Vivo Targeted MR Imaging of Endogenous Neural Stem Cells in Ischemic Stroke.

Directed Differentiation: MRI-Visible siRNA Nanomedicine Directing Neuronal Differentiation of Neural Stem Cells in Stroke (Adv. Funct. Mater. 14/2018)

Vitality-Enhanced Dual-Modal Tracking System Reveals the Dynamic Fate of Mesenchymal Stem Cells for Stroke Therapy

NSC-derived exosomes enhance therapeutic effects of NSC transplantation on cerebral ischemia in mice

Ph-Sensitive, Cerebral Vasculature-Targeting Hydroxyethyl Starch Functionalized Nanoparticles For Improved Angiogenesis And Neurological Function Recovery In Ischemic Stroke

Neural Stem Cells Transfected With Reactive Oxygen Species-Responsive Polyplexes For Effective Treatment Of Ischemic Stroke

Combinatorial intranasal delivery of bone marrow mesenchymal stem cells and insulin-like growth factor-1 improves neurovascularization and functional outcomes following focal cerebral ischemia in mice